A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
for HR+/HER2-negative Breast Cancer
Sites in Philadelphia +8 more locations
Sponsor: Totus Medicines
Sex: Female·Age: 18+
Code: NCT05683418·Phase 1·Recruiting·Listed Jan 2023